IDEAYA Biosciences to Participate in Upcoming May 2025 Investor Relations Events
IDEAYA Biosciences (NASDAQ: IDYA), a precision medicine oncology company, has announced its participation in two major investor relations events in May 2025:
- Barclays Hosted Event on May 8th, 2025 at 11:00 AM ET - featuring a fireside chat with President and CEO Yujiro S. Hata, hosted by Peter Lawson, Managing Director and Equity Research Analyst
- 2025 RBC Capital Markets Global Healthcare Conference on May 20th, 2025 at 8:30 AM ET - including a fireside chat with CEO Hata, hosted by Gregory Renza, Director and Senior Biotechnology Research Analyst
Live audio webcasts will be available on the IDEAYA website's Investors/Events section, with recordings accessible for 30 days after each event.
IDEAYA Biosciences (NASDAQ: IDYA), un'azienda di oncologia di medicina di precisione, ha annunciato la sua partecipazione a due importanti eventi per gli investitori a maggio 2025:
- Evento organizzato da Barclays l'8 maggio 2025 alle 11:00 ET - con una conversazione informale con il Presidente e CEO Yujiro S. Hata, condotta da Peter Lawson, Managing Director e Analista di Equity Research
- Conferenza Globale sulla Sanità 2025 di RBC Capital Markets il 20 maggio 2025 alle 8:30 ET - con una conversazione informale con il CEO Hata, condotta da Gregory Renza, Direttore e Senior Biotechnology Research Analyst
Le dirette audio in webcast saranno disponibili nella sezione Investitori/Eventi del sito web di IDEAYA, con le registrazioni accessibili per 30 giorni dopo ogni evento.
IDEAYA Biosciences (NASDAQ: IDYA), una compañía de oncología de medicina de precisión, ha anunciado su participación en dos importantes eventos para inversores en mayo de 2025:
- Evento organizado por Barclays el 8 de mayo de 2025 a las 11:00 AM ET - con una charla informal con el Presidente y CEO Yujiro S. Hata, presentado por Peter Lawson, Director General y Analista de Investigación de Renta Variable
- Conferencia Global de Salud 2025 de RBC Capital Markets el 20 de mayo de 2025 a las 8:30 AM ET - incluyendo una charla informal con el CEO Hata, presentada por Gregory Renza, Director y Analista Senior de Investigación en Biotecnología
Las transmisiones de audio en vivo estarán disponibles en la sección Inversores/Eventos del sitio web de IDEAYA, con grabaciones accesibles durante 30 días después de cada evento.
IDEAYA Biosciences (NASDAQ: IDYA)는 정밀 의학 암 치료 회사로, 2025년 5월에 열리는 두 주요 투자자 관계 행사에 참여한다고 발표했습니다:
- 바클레이즈 주최 행사 2025년 5월 8일 오전 11시(동부시간) - 사장 겸 CEO 유지로 S. 하타와의 대담, 피터 로슨(매니징 디렉터 겸 주식 연구 분석가) 진행
- 2025 RBC 캐피털 마켓 글로벌 헬스케어 컨퍼런스 2025년 5월 20일 오전 8시 30분(동부시간) - CEO 하타와의 대담, 그레고리 렌자(이사 겸 선임 생명공학 연구 분석가) 진행
라이브 오디오 웹캐스트는 IDEAYA 웹사이트의 투자자/이벤트 섹션에서 제공되며, 각 행사 후 30일간 녹화본도 시청할 수 있습니다.
IDEAYA Biosciences (NASDAQ : IDYA), une entreprise d'oncologie en médecine de précision, a annoncé sa participation à deux événements majeurs pour les investisseurs en mai 2025 :
- Événement organisé par Barclays le 8 mai 2025 à 11h00 ET – avec une discussion informelle avec le Président et CEO Yujiro S. Hata, animée par Peter Lawson, Directeur Général et Analyste en Recherche Actions
- Conférence mondiale sur la santé 2025 de RBC Capital Markets le 20 mai 2025 à 8h30 ET – comprenant une discussion informelle avec le CEO Hata, animée par Gregory Renza, Directeur et Analyste Senior en Recherche Biotechnologie
Des webcasts audio en direct seront disponibles dans la section Investisseurs/Événements du site web d'IDEAYA, avec des enregistrements accessibles pendant 30 jours après chaque événement.
IDEAYA Biosciences (NASDAQ: IDYA), ein Unternehmen für Präzisionsmedizin in der Onkologie, hat seine Teilnahme an zwei wichtigen Investor-Relations-Veranstaltungen im Mai 2025 angekündigt:
- Barclays Hosted Event am 8. Mai 2025 um 11:00 Uhr ET – mit einem Gespräch am Kaminfeuer mit Präsident und CEO Yujiro S. Hata, moderiert von Peter Lawson, Managing Director und Equity Research Analyst
- 2025 RBC Capital Markets Global Healthcare Conference am 20. Mai 2025 um 8:30 Uhr ET – inklusive eines Gesprächs am Kaminfeuer mit CEO Hata, moderiert von Gregory Renza, Direktor und Senior Biotechnology Research Analyst
Live-Audio-Webcasts werden im Bereich Investoren/Veranstaltungen auf der IDEAYA-Website verfügbar sein, mit Aufzeichnungen, die 30 Tage nach jeder Veranstaltung abrufbar sind.
- None.
- None.
Barclays Hosted: Peter Lawson's Catalyst & Key Debate Calls & Investor 1x1's
Thursday, May 8th, 2025 at 11:00 AM ET
- Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Peter Lawson, D.Phil., Managing Director, Equity Research Analyst
2025 RBC Capital Markets Global Healthcare Conference
Tuesday, May 20th, 2025 at 8:30 AM ET
- Fireside chat with Yujiro S. Hata, President and Chief Executive Officer hosted by Gregory Renza, M.D., Director and Senior Biotechnology Research Analyst
A live audio webcast of the conference events, as permitted by the conference host, will be available under the "Investors/Events" section of the IDEAYA website at https://ir.ideayabio.com/events and/or through the conference host. A replay of the webcasts will be accessible for 30 days following the live event.
About IDEAYA Biosciences
IDEAYA is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies. IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality – which represents an emerging class of precision medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's current and future filings with the
Investor and Media Contact
IDEAYA Biosciences
Andres Ruiz Briseno
Chief Accounting Officer
investor@ideayabio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-upcoming-may-2025-investor-relations-events-302438987.html
SOURCE IDEAYA Biosciences, Inc.
FAQ
What investor events will IDEAYA Biosciences (IDYA) attend in May 2025?
How can investors access IDEAYA Biosciences' (IDYA) May 2025 conference presentations?
Who will represent IDEAYA Biosciences (IDYA) at the May 2025 investor conferences?
What time is IDEAYA Biosciences' (IDYA) presentation at the 2025 RBC Capital Markets Healthcare Conference?
